Dyne Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 11/14/2025 | 14.75 M | $186.49 M | 56.24% | 12.95% |
| VANGUARD GROUP INC | 11/07/2025 | 9.76 M | $123.47 M | 27.57% | 8.57% |
| BLACKROCK, INC. | 11/12/2025 | 9.63 M | $121.88 M | 19.27% | 8.46% |
| ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC | 11/13/2025 | 9.13 M | $115.50 M | 0.00% | 8.02% |
| FCPM III SERVICES B.V. | 11/14/2025 | 5.46 M | $69.11 M | 0.00% | 4.80% |
| FMR LLC | 11/13/2025 | 5.40 M | $68.33 M | 2.05% | 4.74% |
| STATE STREET CORP | 11/14/2025 | 5.27 M | $66.65 M | 57.02% | 4.63% |
| SIREN, L.L.C. | 11/13/2025 | 4.73 M | $59.82 M | -2.22% | 4.15% |
| TCG CROSSOVER MANAGEMENT, LLC | 11/17/2025 | 4.62 M | $58.38 M | 22.53% | 4.05% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2025 | 3.55 M | $44.96 M | 11.38% | 3.12% |
| CITADEL ADVISORS LLC | 11/14/2025 | 3.41 M | $43.18 M | 261.64% | 3.00% |
| JPMORGAN CHASE & CO | 11/26/2025 | 3.37 M | $42.57 M | 9.02% | 2.96% |
| ARMISTICE CAPITAL, LLC | 11/17/2025 | 3.06 M | $38.76 M | 19.69% | 2.69% |
| MARSHALL WACE, LLP | 11/13/2025 | 3.01 M | $38.12 M | 572.92% | 2.65% |
| RTW INVESTMENTS, LP | 11/14/2025 | 2.89 M | $36.57 M | 70.98% | 2.54% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 2.87 M | $36.28 M | 27.24% | 2.52% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 11/14/2025 | 2.81 M | $35.58 M | 56.80% | 2.47% |
| VESTAL POINT CAPITAL, LP | 11/14/2025 | 2.78 M | $35.10 M | 281.44% | 2.44% |
| BRAIDWELL LP | 11/14/2025 | 2.73 M | $34.54 M | -16.58% | 2.40% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/14/2025 | 2.72 M | $34.38 M | 80.49% | 2.39% |
| SATURN V CAPITAL MANAGEMENT LLC | 11/14/2025 | 2.67 M | $33.83 M | 83.76% | 2.35% |
| VIVO CAPITAL, LLC | 11/14/2025 | 2.61 M | $33.08 M | 134.53% | 2.30% |
| LOGOS GLOBAL MANAGEMENT LP | 11/14/2025 | 2.40 M | $30.36 M | 26.32% | 2.11% |
| ORBIMED ADVISORS LLC | 11/14/2025 | 2.31 M | $29.27 M | 124.37% | 2.03% |
| VR ADVISER, LLC | 11/14/2025 | 2.17 M | $27.50 M | 0.00% | 1.91% |
| DEEP TRACK CAPITAL, LP | 11/14/2025 | 2.00 M | $25.30 M | 100.00% | 1.76% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 1.90 M | $24.04 M | 41.76% | 1.67% |
| PARADIGM BIOCAPITAL ADVISORS LP | 11/14/2025 | 1.90 M | $24.02 M | 100.00% | 1.67% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 1.72 M | $21.73 M | 1,293.37% | 1.51% |
| BIOIMPACT CAPITAL LLC | 11/14/2025 | 1.45 M | $18.30 M | 0.00% | 1.27% |
| MORGAN STANLEY | 11/14/2025 | 1.42 M | $17.95 M | 4.17% | 1.25% |
| FRANKLIN RESOURCES INC | 11/13/2025 | 1.40 M | $17.69 M | 0.60% | 1.23% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 1.40 M | $17.69 M | -41.35% | 1.23% |
| PALO ALTO INVESTORS LP | 11/14/2025 | 1.26 M | $15.97 M | 376.52% | 1.11% |
| NORTHERN TRUST CORP | 11/14/2025 | 1.04 M | $13.13 M | 23.37% | 0.91% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 1.01 M | $12.74 M | 35.18% | 0.88% |
| SOFINNOVA INVESTMENTS, INC. | 11/14/2025 | 985.83 K | $12.47 M | 60.33% | 0.87% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 11/14/2025 | 910.92 K | $11.52 M | 15.39% | 0.80% |
| CANDRIAM S.C.A. | 11/06/2025 | 833.92 K | $10.55 M | 59.10% | 0.73% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2025 | 829.77 K | $10.50 M | 4.77% | 0.73% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2025 | 824.06 K | $10.42 M | 41.84% | 0.72% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 11/14/2025 | 800.00 K | $10.12 M | 100.00% | 0.70% |
| ARROWMARK COLORADO HOLDINGS LLC | 11/14/2025 | 785.92 K | $9.94 M | 2.04% | 0.69% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 761.11 K | $9.63 M | 48.13% | 0.67% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 11/17/2025 | 729.61 K | $9.23 M | 100.00% | 0.64% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2025 | 710.04 K | $8.98 M | -10.25% | 0.62% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 11/14/2025 | 702.88 K | $8.89 M | -5.66% | 0.62% |
| MPM ASSET MANAGEMENT LLC | 11/14/2025 | 682.38 K | $8.63 M | 0.00% | 0.60% |
| JAIN GLOBAL LLC | 11/14/2025 | 644.08 K | $8.15 M | 8.04% | 0.57% |
| ABRDN PLC | 11/07/2025 | 556.73 K | $7.04 M | 15.04% | 0.49% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Dyne Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 257 institutional investors and hedge funds held shares of Dyne Therapeutics, Inc.. The most heavily invested institutionals were:
JANUS HENDERSON GROUP PLC: 14.75 M
VANGUARD GROUP INC: 9.76 M
BlackRock, Inc.: 9.63 M
Atlas Venture Life Science Advisors, LLC: 9.13 M
FCPM III SERVICES B.V.: 5.46 M
FMR LLC: 5.4 M
136.85% of Dyne Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 164.41 M shares in the last 24 months. This purchase volume represents approximately $2.15 B in transactions.